论文常用三线表模板.docx

1、论文常用三线表模板论文常用三线表模板LT3.1一般资料表1护士一般资料情况（n=500）项目组别频数构成比（%）性别女47895.6男 224.4年龄段（岁）2414929.8252919639.23015531.0婚姻状况单身26052.0已婚24048.0护龄（年）527054.061011523.01111523.0学历中专193.8大专22244.4本科25150.2硕士8 1.6职称护士21442.8护师21042.0主管护师 6913.8副主任护师 7 1.4月夜班次数0次 5811.613次27955.84次及以上16332.6个人年收入（元）4万15430.846万19639.

2、26万15030.0科室专科19939.8非专科30160.2表5 不同年龄段护士专业生活质量得分的比较（S）measurementssensorFSensitivity (mV/v)2425301.6101.7873.0242.699注：* P0.05；1表示与24岁组比较差异有统计学意义。表3 不同组小鼠肝脏P-JNK平均灰度值结果比较（S）分组例数P-JNKFPA组(正常组)8118.995.9515.3860.001*B组(模型对照组)8101.055.20aC组(DMSO组)8102.115.63bD组(低剂量SP600125组)8107.965.36cE组(高剂量SP600125组

3、)8 113.965.50c,d注：*P0.05；a与正常组比较，P0.05；b与模型对照组比较，P0.05；c与DMSO组比较，P0.05；d与低剂量组比较，P0.05。表3 干预组与对照组与减肥支持者沟通情况比较项目类别干预组(n=65)对照组(n=63)2Pn%n%锻炼减肥支持者父母3558.33555.60.510老师11.534.8同学23.134.8父母/老师57.711.6父母/老师/同学1827.71523.8其他46.269.5 主管护师及以上0.040.930.010.921.04 (0.176.45) 年收入（参照组=4万） 46万0.380.390.150.701.46

4、 (0.683.14) 6万0.860.571.520.222.36 (0.777.22) 科室（参照组=非专科）-0.090.470.040.850.91 (0.362.29)Y=2(中度同情疲劳)年龄段（参照组=24 岁）2529岁0.530.580.820.371.69 (0.545.33)30 岁-0.650.600.660.420.52 (0.161.69)文化程度（参照组=中专）大专0.860.4116.450.01*2.36 (1.055.27) *本科及以上0.910.4317.440.01*2.48 (1.075.77) *护龄（参照组=5年）610年0.790.493.05

5、0.082.20 (0.845.75)11年0.540.351.350.251.71 (0.863.41)职称（参照组=护士） 护师-0.330.590.310.580.72 (0.272.59) 主管护师及以上-0.020.890.010.920.98 (0.175.72) 年收入（参照组=4万） 46万0.510.460.640.421.66 (0.684.10) 6万1.150.544.500.03*3.16 (1.099.10) *科室（参照组=非专科）0.160.450.130.721.18 (0.492.81) ：以Y=0 (无同情疲劳)作为参照组，拟合Y=1，2，3时的多分类lo

6、gistic回归方程。*：P0.05。表1 两组乳腺癌患者体温结果比较（S, ）组别例数术前1天手术日术后1天术后3天术后7天观察组3036.60.236.30.436.10.2*36.30.3*36.40.4对照组3036.60.2 36.20.435.20.335.90.436.30.3注：*与对照组比较，P0.05；与术前1天比较，P0.05。表2 两组乳腺癌患者不同时间血压、心率结果比较（S）指标组别术前1天手术日术后1天术后3天术后7天SBP(mm Hg)观察组117.6410.28146.4612.11127.3112.27114.827.64120.139.16对照组149.24

7、7.22161.748.33*156.24 7.61*151.376.34*149.046.77DBP(mm Hg)观察组78.168.1876.898.6377.979.2678.546.4379.087.86对照组76.168.1886.539.3476.018.6674.327.8273.658.02HR(次/min)观察组75.084.74112.0610.2780.767.7378.283.6778.417.24对照组76.084.74117.958.3485.243.8280.463.8379.143.55注：*与对照组比较，P0.05；与术前1天比较，P0.05。表4 两组乳腺癌

8、患者不同时间CRP、IL-6、TNF-结果比较（S）指标组别例数术前1天术后1天术后3天CRP(mg/L)观察组301.260.98 8.762.62*6.731.95*对照组300.980.4611.753.179.692.68IL-6(pg/mL)观察组304.571.415.985.62*3.152.48*对照组304.831.496.863.765.073.07TNF-(pg/mL)观察组308.112.178.572.17*8.211.73*对照组307.221.4210.943.249.312.43注：*与对照组比较，P0.05；与术前1天比较，P0.05。表1联合组和单用组患者治

9、疗前后细胞因子比较（S）组别例数TNF- (ng/L)IL-6 (ng/L)IL-18 (ng/L)治疗前治疗后治疗前治疗后治疗前治疗后联合组5072.3222.8731.0112.45a350.1038.74107.9118.39 a61.1020.7433.9115.39 a单用组5070.3121.7548.5315.51a346.0437.65162.3220.40 a63.0421.6541.3218.40 at0.450 6.2290.53114.0080.458 2.184P0.6530.001*0.5960.001*0.648 0.031*注：联合组为参附+乌司他丁，单用组为乌

10、司他丁；*P0.05；a表示同组内同类细胞因子与治疗前比较P0.05。2.31白细胞参数 对照组WBC、ANC数于术后1、3天比术前1天明显升高（P0.05）。2.32红细胞参数 对照组RBC、 Hb、HCT 3个红细胞参数在手术后1、3天较术前一天显著降低( P0.05)，只有RDWSD值于术后一天较术前一天明显增大（P0.05）（表3）。表3 两组乳腺癌患者不同时间血常规结果比较（S）指标组别例数术前1天术后1天术后3天WBC(109/L)观察组308.251.209.161.15*8.641.33*对照组308.231.1613.811.2711.424.64RBC(1012/L)观察组

11、304.320.244.580.194.600.20对照组304.260.293.190.263.600.31Hb(g/L)观察组30120.075.77116.635.84117.165.37对照组30118.085.79103.278.13110.438.76HCT观察组300.370.020.360.030.360.02对照组300.380.030.310.020.320.03MCV(fL)观察组3079.647.7280.726.2080.565.46对照组3078.858.1183.336.7480.997.32MCH(pg)观察组3028.251.2030.361.1530.641

12、.33对照组3027.271.1628.181.6727.731.834MCHC(g/L)观察组30324.329.24334.589.19341.609.20对照组30334.469.29336.019.26334.709.41RDW-SD(fL)观察组3037.695.0640.135.34*38.255.27对照组3038.085.7949.278.1337.438.76PLT(109/L)观察组30243.3749.02140.5537.43210.5145.02对照组30240.3845.03150.3831.02220.3642.03ANC(109/L)观察组303.861.724.521.60*4.391.67*对照组303.851.118.331.748.991.32注：*与对照组比较，P0.05；与术前1天比较，P0.05。